Drugs / BAY1211163
Trials 1
| Phase | Registry id | Dates | Indication | Sponsor | Status | Outcome |
|---|---|---|---|---|---|---|
| Phase 1 | NCT04609943 | Nov 2020 → Aug 2023 | adult acute respiratory distress syndrome | Bayer | Terminated | No outcome recorded |
Evidence & citations 3 cited values
Every value below carries the sentence it was read from. 1 source stands behind the page.
| Field | Value | Cited text |
|---|---|---|
| Known as | BAY1211163 | ClinicalTrials.gov intervention name — accepted as the source's own label NCT04609943 ↗ |
| Action | Activate | “soluble Guanylate Cyclase (sGC) Activator” NCT04609943 ↗ |
| Route | Inhaled | “by inhalation” NCT04609943 ↗ |